Educational Resources

Educational Resources

Explore the IMPACT Academy educational programs - endorsed by our expert Steering Committee

Featured
LATEST

Recommended Content

COVID-19 and its implications in heart failure
PRESENTATION
COVID-19 and its implications in heart failure
View Content
Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF
PRESENTATION
Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF
View Content
Practicalities of SGLT2 inhibition – pros vs cons
INFOGRAPHIC
Practicalities of SGLT2 inhibition – pros vs cons
View Content
Updates on ESC heart failure guidelines
VIDEO
Updates on ESC heart failure guidelines
View Content
Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin
INFOGRAPHIC
Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin
View Content
Cardiovascular
LATEST

Cardiovascular

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
VIDEO
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
View Content
What did DAPA-HF tell us about the safety of dapagliflozin in heart failure?
INFOGRAPHIC
What did DAPA-HF tell us about the safety of dapagliflozin in heart failure?
View Content
Hiding in plain sight – how to detect heart failure in primary care
VIDEO
Hiding in plain sight – how to detect heart failure in primary care
View Content
Optimizing HF discharge care and follow-up
INFOGRAPHIC
Optimizing HF discharge care and follow-up
View Content
Metabolic
LATEST

Metabolic

Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
VIDEO
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
View Content
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
INFOGRAPHIC
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
View Content
Clinical recommendations for the management of type 2 diabetes
VIDEO
Clinical recommendations for the management of type 2 diabetes
View Content
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
INFOGRAPHIC
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
View Content
Renal
LATEST

Renal

Chronic kidney disease management
VIDEO
Chronic kidney disease management
View Content
Renal protection with SGLT2 inhibitors: what every cardiologist should know
INFOGRAPHIC
Renal protection with SGLT2 inhibitors: what every cardiologist should know
View Content
Kidney outcomes associated with inhibition of SGLT2
VIDEO
Kidney outcomes associated with inhibition of SGLT2
View Content
SGLT2 inhibitors and dapagliflozin in chronic kidney disease
INFOGRAPHIC
SGLT2 inhibitors and dapagliflozin in chronic kidney disease
View Content
Featured
LATEST

Trending Content

The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
PRESENTATION
The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
View Content
Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin
INFOGRAPHIC
Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin
View Content
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
VIDEO
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
View Content
Cardiorenal benefits of SGLT2 inhibitors
PRESENTATION
Cardiorenal benefits of SGLT2 inhibitors
View Content
Diagnosis and co-morbidities of chronic kidney disease
VIDEO
Diagnosis and co-morbidities of chronic kidney disease
View Content